Literature DB >> 23748124

Appropriateness of medication prescribing using the STOPP/START criteria in veterans receiving home-based primary care.

Millie Brahmbhatt1, Kavita Palla, Annette Kossifologos, Dayna Mitchell, Todd Lee.   

Abstract

OBJECTIVE: To evaluate the appropriateness/inappropriateness of medication prescribing using the Screening Tool of Older Person's Prescriptions/Screening Tool to Alert doctors to Right Treatment (STOPP/START) criteria in elderly homebased primary care (HBPC) veterans and to understand the potential impact of the HBPC team on the STOPP/START criteria.
DESIGN: Retrospective chart review between September 1, 2007, and September 30, 2009.
SETTING: Edward Hines, Jr. VA Hospital, Hines, Illinois, a tertiary care referral center. PARTICIPANTS: Two hundred patients 65 years of age and older who had an initial interdisciplinary evaluation conducted by the HBPC team. Exclusion criteria included admission to the hospital between the initial and follow-up medication review, admission to the HBPC program for palliative or hospice care, or death before completion of a follow-up evaluation. INTERVENTION: Appropriateness/inappropriateness of medication prescribing was assessed by comparing the medication list at the initial pharmacist medication review and follow-up review. Initial and follow-up STOPP and START scores were calculated for each patient. MAIN OUTCOME MEASURES: The primary outcome was to evaluate the appropriateness/inappropriateness of medication prescribing using the STOPP/START criteria. The secondary outcome was to understand the potential impact of the HBPC team on the STOPP/START criteria.
RESULTS: There was a statistically significant decrease in the STOPP score between the initial and follow-up medication review (P = 0.0014). There was not a statistically significant increase in the START score between the initial and follow-up medication review (P = 0.5720).
CONCLUSIONS: A statistically significant decrease in the STOPP score was found. Although the START score increased, the change was not found to be statistically significant.

Entities:  

Mesh:

Year:  2013        PMID: 23748124     DOI: 10.4140/TCP.n.2013.361

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  7 in total

Review 1.  The scope of drug-related problems in the home care setting.

Authors:  Carla Meyer-Massetti; Christoph R Meier; B Joseph Guglielmo
Journal:  Int J Clin Pharm       Date:  2018-01-11

2.  Psychotropic medication use patterns in home-based primary care: A scoping review.

Authors:  Nina Vadiei; Carol L Howe; Beth Zerr; Nicholas Ladziak; Mindy J Fain; Jeannie K Lee
Journal:  Ment Health Clin       Date:  2020-09-30

3.  Impact of Pharmacist-Provided Medication Therapy Management on Healthcare Quality and Utilization in Recently Discharged Elderly Patients.

Authors:  Jordan D Haag; Amanda Z Davis; Robert W Hoel; Jeffrey J Armon; Laura J Odell; Ross A Dierkhising; Paul Y Takahashi
Journal:  Am Health Drug Benefits       Date:  2016-07

4.  Potentially inappropriate prescribing in older primary care patients.

Authors:  Sandra Vezmar Kovačević; Mika Simišić; Svetlana Stojkov Rudinski; Milica Ćulafić; Katarina Vučićević; Milica Prostran; Branislava Miljković
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

5.  Impact of Pharmacist-Conducted Comprehensive Medication Reviews for Older Adult Patients to Reduce Medication Related Problems.

Authors:  Whitney J Kiel; Shaun W Phillips
Journal:  Pharmacy (Basel)       Date:  2017-12-31

6.  [Inappropriate prescribing in polymedicated patients over 64 years-old in primary care].

Authors:  Josefina Filomena Paci; Marta García Alfaro; Francisco Javier Redondo Alonso; María Isabel Fernández San-Martín
Journal:  Aten Primaria       Date:  2014-08-10       Impact factor: 1.137

7.  National Cohort Study of Homebound Persons Living With Dementia: Antibiotic Prescribing Trends and Opportunities for Antibiotic Stewardship.

Authors:  Rupak Datta; Terri Fried; John R O'Leary; Andrew R Zullo; Heather Allore; Ling Han; Manisha Juthani-Mehta; Andrew Cohen
Journal:  Open Forum Infect Dis       Date:  2022-09-03       Impact factor: 4.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.